Shares of GlaxoSmithKline Pharmaceuticals Ltd. shed over 2.5%, the steepest fall inover a week afterthe company reported net income forthe third quarter that missedthe average analyst estimate, for the quarter-ended December.
Shares of GlaxoSmithKline Pharmaceuticals Ltd. shed over 2.5%, the steepest fall inover a week afterthe company reported net income forthe third quarter that missedthe average analyst estimate, for the quarter-ended December.